“I have more gray hair in my beard – and less overall hair of any color – after a year like we’ve just had,” Wide Open Agriculture (ASX: WOA) CEO Jay Albany remarked, reflecting on the Company’s 2023—the year in which it was suspended from the ASX for six months. Besides reeling under the impact
Read More
Aussie pharma development company Algorae Pharmaceuticals (ASX: 1AI) has partnered with HL Pharma, an Australian company registered with the Victorian Department of Health, for the sourcing, supply, and distribution of various cannabinoid compounds for research purposes. The collaboration is governed by a comprehensive three-year agreement, adhering to Good Distribution Practice (GDP). Under the terms, HL
Read More
Seasons Greetings from the Team at The Sentiment! We’ll now be taking some time off to enjoy with our families but below are a few of the most popular stories of 2023 and look forward to returning in the New Year. ASX News Scarless healing one step closer as Fiona Wood-led clinical trials demonstrate collagen
Read More
Biotech company PharmAust (ASX: PAA) has been invited by not-for-profit organisation FightMND to submit a comprehensive grant application which could grant up to $1.8 million to fund Phase 2 and 3 clinical trials in an effort to find a treatment for Motor Neurone Disease (MND) Earlier this month, PharmAust submitted a Letter of Intent to
Read More
Picking itself up after a year of losses, financial services company Earlypay Limited (ASX: EPY) has secured a new invoice and trade finance warehouse facility with an initial senior funding commitment limit of $220 million. The financial settlement of the facility is set to take place in January 2024. In addition to this milestone, Earlypay
Read More
It’s a new name, new game energy, as music company Vinyl (ASX: VNL)—formerly Jaxsta—acquires entertainment giant The Brag Media, the Australian publisher of Variety magazine and Rolling Stone AU/NZ. Vinyl will fully acquire the publisher, including its premium network of mastheads and events funded by a new investment by WiseTech Global (ASX: WTC) Founder and
Read More
In Chile, one in eight adults have diabetes. The number of people with the condition there has risen almost 50% in the past ten years. By 2030, the healthcare spending on diabetes in Chile is set to surpass $4 billion. Chile’s healthcare needs demand companies like medical tech company Proteomics (ASX: PIQ) that emphasise early
Read More
The first four months of FY24 have not been kind on clothing retailer KMD Brands (ASX: KMD), the Group behind the ubiquitous winterwear retailer Kathmandu (spotting Kathmandu jackets during Aussie winters could very well be a drinking game). However, with winters having passed, KMD has reported a 12.5% decline in group sales compared to the
Read More
In a significant move signalling strong confidence in Syntara (ASX: SNT) and their drugs in development, institutional investors have subscribed for $10 million of shares, driven by the immediate commercial prospects of their leading drug SNT-5505. The funds will also support an emerging pipeline of drugs addressing Parkinson’s disease and skin scar trials. The $10m
Read More
Fertility specialists Monash IVF (ASX: MVF) appears to have found fertile ground for growth, as it locks in the acquisition of Perth-based IVF and fertility clinic Fertility North. Fertility North services Perth’s northern suburbs, helping MVF attract new clientele. Monash IVF will acquire 80% of Fertility North through an initial upfront cash payment estimated at
Read More
